Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 2022 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

By: MattB
Views: 1673

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 1

By: MattB
Views: 1867

Medication Therapy Management Part D Programs

By: MattB
Views: 1700

Pharmacoeconomics

By: MattB
Views: 3443

What is Managed Care Pharmacy?

By: MattB
Views: 1649

Granulation

By: ahaskk
Views: 2571

COVID-19 immunology research

By: MattB
Views: 1448

Tuberculosis

By: iFuzzle11
Views: 1321

India Pharma 2020 - Propelling access and acceptance realizing true potential

By: KhushbuSG
Views: 1575

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019

By: MattB
Views: 1423

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z